Peptoid CCK receptor antagonists: pharmacological evaluation of CCK A , CCK B and mixed CCK A/B receptor antagonists

By Singh L.   Field M.J.   Hill D.R.   Horwell D.C.   McKnight A.T.   Roberts E.   Tang K.W.   Woodruff G.N.  

European Journal of Pharmacology, Vol. 286, Iss. 2, 1995-11 ,pp. : 185-191

Elsevier

Access to resources Recommend Favorite

A selective CCK B receptor antagonist potentiates -, but not -opioid receptor-mediated antinociception in the formalin test

By Noble F.   Blommaert A.   Fournie-Zaluski M.-C.   Roques B.P.  

European Journal of Pharmacology, Vol. 273, Iss. 1, 1995-01 ,pp. : 145-151

Elsevier

Access to resources Recommend Favorite

Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK B receptor antagonist, l-365,260, in rat brain

By Ge J.   Long S.K.   Kilpatrick I.C.  

European Journal of Pharmacology, Vol. 345, Iss. 2, 1998-03 ,pp. : 163-170

Elsevier

Access to resources Recommend Favorite

Effect of the selective CCK B receptor antagonist LY288513 on conditioned fear stress in rats

By Izumi T.   Inoue T.   Tsuchiya K.   Hashimoto S.   Ohmori T.   Koyama T.  

European Journal of Pharmacology, Vol. 300, Iss. 1, 1996-04 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite

Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCK B receptor antagonist

By Valverde O.   Blommaert A.G.S.   Fournie-Zaluski M.-C.   Roques B.P.   Maldonado R.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 79-93

Elsevier

Access to resources Recommend Favorite